<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Lemaitre Vascular Inc — News on 6ix</title>
<link>https://6ix.com/company/lemaitre-vascular-inc</link>
<description>Latest news and press releases for Lemaitre Vascular Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 14 Apr 2026 20:54:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/lemaitre-vascular-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835925278dffbe2df102d3d.webp</url>
<title>Lemaitre Vascular Inc</title>
<link>https://6ix.com/company/lemaitre-vascular-inc</link>
</image>
<item>
<title>LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026</title>
<link>https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-will-announce-first-quarter-2026-earnings-results-on-may-5-2026</link>
<guid isPermaLink="true">https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-will-announce-first-quarter-2026-earnings-results-on-may-5-2026</guid>
<pubDate>Tue, 14 Apr 2026 20:54:00 GMT</pubDate>
<description>BURLINGTON, Mass., April 14, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2026 financial results on Tuesday, May 5, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to a</description>
</item>
<item>
<title>LeMaitre Q4 2025 Financial Results</title>
<link>https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-q4-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-q4-2025-financial-results</guid>
<pubDate>Wed, 25 Feb 2026 21:05:00 GMT</pubDate>
<description>BURLINGTON, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q4 2025 results, announced a quarterly dividend of $0.25/share (+25%), and provided guidance. Q4 2025: Sales $64.5mm, +16% (+15% organic) vs. Q4 2024Gross margin 71.7% (+240 bps)Op. income $18.8mm (+47%)Op. margin 29%Diluted EPS $0.68 (+39%)Cash up $16.1mm sequentially to $359.1mm Grafts (+27%), valvulotomes (+20%), and carotid shunts</description>
</item>
<item>
<title>LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026</title>
<link>https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-announce-fourth-quarter-2025-144700856</link>
<guid isPermaLink="true">https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-announce-fourth-quarter-2025-144700856</guid>
<pubDate>Wed, 11 Feb 2026 14:47:00 GMT</pubDate>
<description>BURLINGTON, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2025 financial results on Wednesday, February 25, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing t</description>
</item>
<item>
<title>LeMaitre to Participate in Upcoming Investor Conferences</title>
<link>https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-participate-upcoming-investor-conferences-2025-11-12</link>
<guid isPermaLink="true">https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-participate-upcoming-investor-conferences-2025-11-12</guid>
<pubDate>Wed, 12 Nov 2025 05:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming</description>
</item>
<item>
<title>LeMaitre Q3 2025 Financial Results</title>
<link>https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-q3-2025-financial-results-2025-11-06</link>
<guid isPermaLink="true">https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-q3-2025-financial-results-2025-11-06</guid>
<pubDate>Thu, 06 Nov 2025 05:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today</description>
</item>
<item>
<title>LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025</title>
<link>https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-will-announce-third-quarter-2025-earnings-results-november-6-2025-2025-10-09</link>
<guid isPermaLink="true">https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-will-announce-third-quarter-2025-earnings-results-november-6-2025-2025-10-09</guid>
<pubDate>Thu, 09 Oct 2025 04:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2025</description>
</item>
<item>
<title>LeMaitre to Participate at Upcoming Investor Conferences in September</title>
<link>https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-participate-upcoming-investor-conferences-september-2025-08-28</link>
<guid isPermaLink="true">https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-participate-upcoming-investor-conferences-september-2025-08-28</guid>
<pubDate>Thu, 28 Aug 2025 04:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in four upcoming</description>
</item>
<item>
<title>LeMaitre Q2 2025 Financial Results</title>
<link>https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-q2-2025-financial-results-200500146</link>
<guid isPermaLink="true">https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-q2-2025-financial-results-200500146</guid>
<pubDate>Tue, 05 Aug 2025 20:05:00 GMT</pubDate>
<description>BURLINGTON, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q2 2025 results, announced a quarterly dividend of $0.20/share, and provided guidance. Q2 2025: Sales $64.2mm, +15% (+15% organic)Gross margin 70.0%, +110 bpsOp. income $16.1mm, +12%Op. margin 25%Earnings per diluted share $0.60, +16%Cash up $16.9mm sequentially to $319.5mm Catheters (+27%) and grafts (+19%) drove Q2 sales growth. EME</description>
</item>
<item>
<title>LeMaitre Will Announce Second Quarter 2025 Earnings Results August 5, 2025</title>
<link>https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-will-announce-second-quarter-2025-earnings-results-august-5-2025-2025-07-08</link>
<guid isPermaLink="true">https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-will-announce-second-quarter-2025-earnings-results-august-5-2025-2025-07-08</guid>
<pubDate>Tue, 08 Jul 2025 04:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2025</description>
</item>
<item>
<title>LeMaitre to Present at the Bank of America Securities 2025 Healthcare Conference</title>
<link>https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-present-bank-america-securities-2025-healthcare-conference-2025-05-05</link>
<guid isPermaLink="true">https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-present-bank-america-securities-2025-healthcare-conference-2025-05-05</guid>
<pubDate>Mon, 05 May 2025 04:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the</description>
</item>
<item>
<title>LeMaitre Q1 2025 Financial Results</title>
<link>https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-q1-2025-financial-results-2025-05-01</link>
<guid isPermaLink="true">https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-q1-2025-financial-results-2025-05-01</guid>
<pubDate>Thu, 01 May 2025 04:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today</description>
</item>
<item>
<title>LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025</title>
<link>https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-will-announce-first-quarter-2025-earnings-results-may-1-2025-2025-04-07</link>
<guid isPermaLink="true">https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-will-announce-first-quarter-2025-earnings-results-may-1-2025-2025-04-07</guid>
<pubDate>Mon, 07 Apr 2025 04:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2025</description>
</item>
<item>
<title>LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference</title>
<link>https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-present-24th-annual-needham-virtual-healthcare-conference-2025-04-01</link>
<guid isPermaLink="true">https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-present-24th-annual-needham-virtual-healthcare-conference-2025-04-01</guid>
<pubDate>Tue, 01 Apr 2025 04:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will present at the 24th Annual</description>
</item>
<item>
<title>LeMaitre to Participate at Upcoming Investor Conferences in March</title>
<link>https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-participate-upcoming-investor-conferences-march-2025-03-03</link>
<guid isPermaLink="true">https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-participate-upcoming-investor-conferences-march-2025-03-03</guid>
<pubDate>Mon, 03 Mar 2025 05:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., March 03, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three</description>
</item>
<item>
<title>LeMaitre Q4 2024 Financial Results</title>
<link>https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-q4-2024-financial-results-2025-02-27</link>
<guid isPermaLink="true">https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-q4-2024-financial-results-2025-02-27</guid>
<pubDate>Thu, 27 Feb 2025 05:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants, and services, reported Q4 2024 results,</description>
</item>
<item>
<title>LeMaitre Will Announce Fourth Quarter 2024 Earnings Results February 27, 2025</title>
<link>https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-will-announce-fourth-quarter-2024-earnings-results-february-27-2025-2025-01</link>
<guid isPermaLink="true">https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-will-announce-fourth-quarter-2024-earnings-results-february-27-2025-2025-01</guid>
<pubDate>Mon, 27 Jan 2025 05:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., Jan. 27, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2024</description>
</item>
<item>
<title>LeMaitre Vascular Prices $150 Million Convertible Senior Notes</title>
<link>https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-vascular-prices-150-million-convertible-senior-notes-2024-12-16</link>
<guid isPermaLink="true">https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-vascular-prices-150-million-convertible-senior-notes-2024-12-16</guid>
<pubDate>Mon, 16 Dec 2024 05:00:00 GMT</pubDate>
<description>BOSTON, Dec. 16, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (“LeMaitre”) (Nasdaq: LMAT) today announced the pricing of its offering of $150,000,000</description>
</item>
<item>
<title>LeMaitre Vascular Announces Proposed Convertible Senior Notes Offering</title>
<link>https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-vascular-announces-proposed-convertible-senior-notes-offering-2024-12-16</link>
<guid isPermaLink="true">https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-vascular-announces-proposed-convertible-senior-notes-offering-2024-12-16</guid>
<pubDate>Mon, 16 Dec 2024 05:00:00 GMT</pubDate>
<description>BOSTON, Dec. 16, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (“LeMaitre”) (Nasdaq: LMAT) today announced its intention to offer, subject to market and</description>
</item>
<item>
<title>LeMaitre to Participate at Upcoming Investor Conferences in December</title>
<link>https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-participate-upcoming-investor-conferences-december-2024-11-25</link>
<guid isPermaLink="true">https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-participate-upcoming-investor-conferences-december-2024-11-25</guid>
<pubDate>Mon, 25 Nov 2024 05:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., Nov. 25, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor</description>
</item>
<item>
<title>LeMaitre to Participate at Upcoming Investor Conferences in November</title>
<link>https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-participate-upcoming-investor-conferences-november-2024-11-01</link>
<guid isPermaLink="true">https://6ix.com/company/lemaitre-vascular-inc/news/lemaitre-participate-upcoming-investor-conferences-november-2024-11-01</guid>
<pubDate>Fri, 01 Nov 2024 04:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three</description>
</item>
</channel>
</rss>